Africa Resilience Initiative

submitted by George Hurlburt

A group of volunteer medical workers carry the bodies of Ebola victims to a car in order to bury them in Kptema graveyard in Kenema, Sierra Leone, on August 24, 2014. Mohammed Elshamy/Anadolu Agency/Getty Images

wired.com - by Erica Check Hayden - June 30, 2015

. . . The patients held the answer. If they survived, they carried antibodies that targeted the very viruses that had almost killed them. The samples he’d been working with didn’t contain antibodies, but if he could get blood from survivors, he might be able to figure out how to make the same antibodies that their immune systems had produced. It would not be easy or fast, but he couldn’t stand by while more people lost their lives—if not in this outbreak, then in the next one, or the next one after that. It was time for a new plan. . . .

. . . Once your body knows how to make antibodies specific to a disease, it never forgets . . . So physicians use survivor serum in the hope that amid the trillions of antibodies an adult human can make, the ones that fight a specific disease will be in the mix. It’s not a new idea.

(READ COMPLETE ARTICLE)

CLICK HERE - Global Health Media - The Story of Ebola - English

June 26, 2015

This animation—produced in collaboration with International Federation of Red Cross and Red Crescent Societies, UNICEF, and Yoni Goodman—brings to life key messages that help people see and understand how Ebola spreads and how to protect themselves and their communities.

CLICK HERE - About the film:

The story features a young girl whose grandfather dies from Ebola and puts the rest of her family at risk. The film makes visible the invisible Ebola germs to help people see and understand how Ebola spreads and how to protect themselves. Critical messages are woven through the story so that people better understand Ebola, see themselves within the context of an outbreak, and see how to act in ways that can keep themselves safe from the disease and protect their communities.

Trial to examine long-term health effects of Ebola virus disease

nih.gov - June 17, 2015

The Liberia-U.S. clinical research partnership known as PREVAIL has launched a study of people in Liberia who have survived Ebola virus disease (EVD) within the past two years. The study investigators hope to better understand the long-term health consequences of EVD, determine if survivors develop immunity that will protect them from future Ebola infection, and assess whether previously EVD-infected individuals can transmit infection to close contacts and sexual partners. The study, sponsored by the Ministry of Health of Liberia and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will take place at various sites in Liberia and is expected to enroll approximately 7,500 people, including 1,500 people of any age who survived EVD and 6,000 of their close contacts.